CORT - Corcept Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CORT is currently covered by 5 analysts with an average price target of $95.89. This is a potential upside of $18.33 (23.63%) from yesterday's end of day stock price of $77.56.

Corcept Therapeutics's activity chart (see below) currently has 46 price targets and 77 ratings on display. The stock rating distribution of CORT is 7.69% HOLD and 92.31% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.9% with an average time for these price targets to be met of 256 days.

Highest price target for CORT is $145, Lowest price target is $131, average price target is $97.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 06-May-2025. First documented stock forecast 12-Oct-2015.

Currently out of the existing stock ratings of CORT, 3 are a HOLD (7.69%), 36 are a BUY (92.31%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$145

$67.44 (86.95%)

$150

25 days ago
(06-May-2025)

15/19 (78.95%)

$74.26 (104.98%)

134

Buy

$131

$53.44 (68.90%)

$78

1 months 28 days ago
(03-Apr-2025)

7/8 (87.5%)

$51.63 (65.05%)

86

Buy

$142

$64.44 (83.08%)

$130

1 months 30 days ago
(01-Apr-2025)

7/9 (77.78%)

$50.07 (54.47%)

290

Buy

$38

$13.94 (57.94%)

$29

1 years 6 months 26 days ago
(06-Nov-2023)

2/3 (66.67%)

$12.09 (46.66%)

37

Hold

$29

$-48.56 (-62.61%)

$26

1 years 9 months 28 days ago
(03-Aug-2023)

4/4 (100%)

$-2.24 (-7.17%)

262

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CORT (Corcept Therapeutics) average time for price targets to be met?

On average it took 256 days on average for the stock forecasts to be realized with a an average price target met ratio 91.9

Which analyst has the current highest performing score on CORT (Corcept Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 3 price targets and 5 ratings on CORT

Which analyst is the currently most bullish on CORT (Corcept Therapeutics)?

Swayampakula Ramakanth with highest potential upside - $67.44

Which analyst is the currently most reserved on CORT (Corcept Therapeutics)?

David Buck with lowest potential downside - -$66.56

Corcept Therapeutics in the News

Is Corcept Therapeutics Inc. (NASDAQ:CORT) the Best Growth Stock to Buy for the Next 3 Years?

We recently published a list of the 15 Best Growth Stocks to Buy for the Next 3 Years. In this article, we are going to take a look at where Corcept Therapeutics Inc. (NASDAQ:CORT) stands against other growth stocks to buy for the next 3 years. On April 29, Dan Ives of Wedbush Securities joined...

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst performers in the branded pharmaceuticals industry. The branded pharmaceutical industry relies on a high-cost, high-reward business model, driven by substantial...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?